MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, USAQ made $2,691,741 in revenue. $457,417 in net income. Net profit margin of 16.99%.

Income Overview

Revenue
$2,691,741
Net Income
$457,417
Net Profit Margin
16.99%
EPS
$0.02
Unit: Dollar
Revenue Breakdown
    • Integrated Service Program
    • Allergy Diagnostic Kit Sales
    • Immunotherapy Treatment Sales
    • Others

Income Statement
2025-12-31
2024-12-31
Revenue
2,691,741 2,131,926
Cost of revenue
880,892 774,036
Gross profit
1,810,849 1,357,890
Sales and marketing
683,477 509,065
General and administrative
439,143 276,496
Research and development
484,873 294,479
Amortization
72,112 72,112
Total operating expenses
1,679,605 1,152,152
Net operating income
131,244 205,738
Interest expense
237,413 465,055
Other income
82 78
Gain on extinguishment of debt, net
665,755 -
Loss on conversion of debt
102,251 -
Income (loss) before income taxes
457,417 -259,239
Net income (loss)
457,417 -259,239
Basic EPS
0.04 -0.03
Diluted EPS
0.02 -0.03
Basic Average Shares
11,297,235 10,288,458
Diluted Average Shares
19,342,119 10,288,458
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Integrated Service Program$1,121,134 (74.30%↑ Y/Y)Allergy Diagnostic KitSales$823,108 (-1.19%↓ Y/Y)Immunotherapy Treatment Sales$487,762 (19.16%↑ Y/Y)Clinical Study Revenue$133,650 (0.00%↑ Y/Y)Subscription Revenue$43,731 (-19.79%↓ Y/Y)Shipping And Handling$41,670 (16.10%↑ Y/Y)Training And OtherRevenue$40,686 (82.09%↑ Y/Y)Revenue$2,691,741 (26.26%↑ Y/Y)Gross profit$1,810,849 (33.36%↑ Y/Y)Cost of revenue$880,892 (13.81%↑ Y/Y)Gain onextinguishment of debt, net$665,755 Net operatingincome$131,244 (-36.21%↓ Y/Y)Other income$82 (5.13%↑ Y/Y)Total operatingexpenses$1,679,605 (45.78%↑ Y/Y)Income (loss) beforeincome taxes$457,417 (276.45%↑ Y/Y)Interest expense$237,413 (-48.95%↓ Y/Y)Loss on conversion ofdebt$102,251 Sales and marketing$683,477 (34.26%↑ Y/Y)Research and development$484,873 (64.65%↑ Y/Y)General andadministrative$439,143 (58.82%↑ Y/Y)Amortization$72,112 (0.00%↑ Y/Y)Net income (loss)$457,417 (276.45%↑ Y/Y)

QHSLab, Inc. (USAQ)

QHSLab, Inc. (USAQ)